Bearing in mind that the population incidence of breast cancer is about 10 times the incidence of ovarian cancer, these findings indicated that the risks for breast and ovarian cancers were similar in carriers of the Norwegian founder path_BRCA1 variants, but with later onset of ovarian cancer. Here, BRCA1 is linked to ovarian carcinoma.